Media Partners

CEP Media Partner

CEP, the flagship publication of the American Institute of Chemical Engineers (AIChE), reaches nearly 18,500 chemical engineers around the world in print, most with specifying or buying authority. New in 2020, CEP has expanded digitally to reach all 60,000 members through a flipbook in addition to the mobile app. Each issue is packed with practical information today’s engineers can put to work on current and future projects. CEP covers technical advances in the global chemical process and related industries, business news, and career advice. It provides the field’s most trusted analysis of issues in safety, environmental management, fluids and solids handling, reactions and separations, and more. CEP also offers showcase, product digest, and classified advertising opportunities.

CSI 2013-18 Web (002)

Chemical Search International specialises exclusively in executive search, talent acquisition and professional career development services for the global chemicals and related sectors such as polymers, materials, natural resources and biosciences. We also own ChemExecSM | Executive Network, an exclusive online professional network dedicated to these same industries and which offers faster, simpler professional networking just when you need it. We have offices in London, New York and Singapore. Please contact us to discuss your company’s recruitment needs or to discuss your own personal career.

Pharmavoice logo

PharmaVOICE magazine reaches more than 46,000 BPA qualified subscribers and 60,000 users with its digital edition. PharmaVOICE is the forum that allows business leaders to engage in a candid dialogue on the challenges and trends impacting the industry. PharmaVOICE provides readers with insightful and thought-provoking commentary in a multiple-perspective format through forums, topics, and articles covering a range of issues from molecule through market. PharmaVOICE subscribers are also kept abreast of the latest trends and information through additional media resources, including Social Media, WebLinx Interactive WebSeminars, Podcasts, Videocasts, White Papers, E-Surveys and e-Alerts.

ps headshot

Pharma Scientist is a leading online news portal providing the latest in pharmaceutical sciences from around the world, through industry reports and events.

We specialise providing news and events in advanced therapies, controlled substances, drug discovery and development, pharma and biopharma, logistics and manufacturing and digital health tech. News is researched and created organically by our industry analysts and editors from around the world, who also provides us exclusive industry reports.

Subscribe to the Pharma Scientist today, and receive the latest in pharmaceutical sciences from around the world, straight to your inbox!
Contact us for article submissions, partnerships, advertising and general queries:

pharmaphorum - Media Partner

pharmaphorum uses content to connect the pharmaceutical industry and other innovators to advance healthcare, leveraging its own global publications and delivering direct content marketing, medical and communications services to clients in the healthcare sector., and its associated digital magazine Deep Dive, is a leading online destination for healthcare and pharmaceutical industry news, insight and debate.

pharmaphorum connect is a consultancy providing first-class strategic and creative content-driven stakeholder engagement services to pharmaceutical companies and other healthcare organisations.

Founded in the UK, it is led by CEO and founder Paul Tunnah, a recognised author, speaker and industry advisor on content marketing, communications and digital innovation, having worked with many of the world’s leading pharmaceutical companies and the broader ecosystem of healthcare organisations.

processes - media partner

Processes (ISSN 2227-9717; CODEN: PROCCO; IF:2.753) is an international peer-reviewed open access journal on processes in chemistry, biochemistry, biology, materials, and related process/systems engineering research fields. The journal publishes regular research papers, communications, letters, short notes and reviews. Our aim is to encourage researchers to publish their experimental, theoretical and computational results in as much detail as necessary. There is no restriction on paper length or number of figures and tables. Manuscripts are peer-reviewed, and a first decision is provided to authors approximately 13.3 days after submission; the process from acceptance to publication is undertaken in 3.3 days. Lastly, it is indexed in the Science Citation Index Expanded (Web of Science) and Inspec (IET). Covered in Scopus from Vol. 5 (2017).